SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

CEL-SCI announces U.S. approval study for Multikine with 212 patients

CEL-SCI announced a U.S. approval study of Multikine involving 212 patients.

CVM

Related stories